AGTC insider filings

APPLIED GENETIC TECHNOLOGIES CORP — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-12-01. Screen AGTC transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AGTC between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — APPLIED GENETIC TECHNOLOGIES CORP

FiledFormInsiderReported transactionsSource
2022-12-014Robinson James A. Jr. — DirectorDisposition to issuer (D): 25,000 (derivative)EDGAR
2022-12-014Rosen James — DirectorCode (U): 1,000 · Disposition to issuer (D): 9,375 (derivative) · Disposition to issuer (D): 4,688 (derivative) · Disposition to issuer (D): 6,200 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · +4 moreEDGAR
2022-12-014Aliski William — DirectorCode (U): 8,500 · Disposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 14,000 (derivative)EDGAR
2022-12-014Hashad Yehia — DirectorDisposition to issuer (D): 25,000 (derivative) · Disposition to issuer (D): 14,000 (derivative)EDGAR
2022-12-014Koenig Scott — DirectorCode (U): 34,246 · Disposition to issuer (D): 14,285 (derivative) · Disposition to issuer (D): 9,375 (derivative) · Disposition to issuer (D): 4,688 (derivative) · Disposition to issuer (D): 6,200 (derivative) · Disposition to issuer (D): 8,000 (derivative) · +5 moreEDGAR
2022-12-014Reynolds Gerald Anthony — Chief Accounting OfficerCode (U): 8,506 · Disposition to issuer (D): 42,500 · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 30,000 (derivative) · Disposition to issuer (D): 34,500 (derivative)EDGAR
2022-12-014Scaria Abraham — Chief Scientific OfficerDisposition to issuer (D): 220,000 (derivative) · Disposition to issuer (D): 124,500 (derivative)EDGAR
2022-12-014Potter Stephen W — Chief Business OfficerCode (U): 47,133 · Disposition to issuer (D): 8,750 · Disposition to issuer (D): 131,049 (derivative) · Disposition to issuer (D): 51,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · Disposition to issuer (D): 50,000 (derivative) · +5 moreEDGAR
2022-12-014DOyley-Gay Hope — General CounselDisposition to issuer (D): 180,000 (derivative) · Disposition to issuer (D): 147,900 (derivative)EDGAR
2022-12-014Schneider Susan — Chief Medical OfficerDisposition to issuer (D): 180,000 (derivative) · Disposition to issuer (D): 142,300 (derivative)EDGAR
2022-12-014Lieber Jonathan I — Chief Financial OfficerDisposition to issuer (D): 202,000 (derivative) · Disposition to issuer (D): 154,700 (derivative)EDGAR
2022-12-014Washer Susan B. — President and CEO, DirectorCode (U): 143,021 · Disposition to issuer (D): 140,000 (derivative) · Disposition to issuer (D): 99,156 (derivative) · Disposition to issuer (D): 55,780 (derivative) · Disposition to issuer (D): 80,000 (derivative) · Disposition to issuer (D): 80,000 (derivative) · +6 moreEDGAR
2022-12-014VANLENT ANNE — DirectorDisposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 8,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 12,000 (derivative) · +1 moreEDGAR
2022-12-014HURWITZ EDWARD — DirectorCode (U): 25,672 · Code (U): 1,800 · Disposition to issuer (D): 9,375 (derivative) · Disposition to issuer (D): 4,688 (derivative) · Disposition to issuer (D): 6,200 (derivative) · Disposition to issuer (D): 8,000 (derivative) · +5 moreEDGAR
2022-08-244Reynolds Gerald Anthony — Chief Accounting OfficerGrant/award (A): 30,000 @ $0EDGAR
2022-08-244DOyley-Gay Hope — General CounselGrant/award (A): 147,900 (derivative) @ $0EDGAR
2022-08-244Potter Stephen W — Chief Business OfficerGrant/award (A): 133,100 (derivative) @ $0EDGAR
2022-08-244Scaria Abraham — Chief Scientific OfficerGrant/award (A): 124,500 (derivative) @ $0EDGAR
2022-08-244Schneider Susan — Chief Medical OfficerGrant/award (A): 142,300 (derivative) @ $0EDGAR
2022-08-244Lieber Jonathan I — Chief Financial OfficerGrant/award (A): 154,700 (derivative) @ $0EDGAR
2022-08-244Washer Susan B. — President and CEO, DirectorGrant/award (A): 442,000 (derivative) @ $0EDGAR
2022-07-014Potter Stephen W — Chief Business OfficerSale (S): 8,070 @ $0.77EDGAR
2022-05-314Reynolds Gerald Anthony — Chief Accounting OfficerSale (S): 3,994 @ $0.85EDGAR
2022-02-224Washer Susan B. — President and CEO, DirectorOption exercise (M): 120,686 @ $0.35 · Sale (S): 9,950 @ $2.18 · Option exercise (M): 120,686 (derivative) @ $0EDGAR
2021-12-154DOyley-Gay Hope — General CounselGrant/award (A): 180,000 (derivative) @ $0EDGAR
2021-12-074Scaria Abraham — Chief Scientific OfficerGrant/award (A): 220,000 (derivative) @ $0EDGAR
2021-12-024Robinson James A. Jr. — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-12-024Rosen James — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-12-024Magovcevic-Liebisch Ivana — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-12-024Koenig Scott — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-12-024Hashad Yehia — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-12-024Aliski William — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-12-024VANLENT ANNE — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-12-024HURWITZ EDWARD — DirectorGrant/award (A): 14,000 (derivative) @ $0EDGAR
2021-11-164Schneider Susan — Chief Medical OfficerGrant/award (A): 180,000 (derivative) @ $0EDGAR
2021-11-034Washer Susan B. — President and CEO, DirectorOption exercise (M): 3,877 @ $3.50 · Option exercise (M): 3,877 (derivative) @ $0EDGAR
2021-09-214Lieber Jonathan I — Chief Financial OfficerGrant/award (A): 202,000 (derivative) @ $0EDGAR
2021-08-184Hashad Yehia — DirectorGrant/award (A): 25,000 (derivative) @ $0EDGAR
2021-08-174Potter Stephen W — Chief Business OfficerTax withholding (F): 5,724 @ $3.58EDGAR
2021-08-064Reynolds Gerald Anthony — Chief Accounting OfficerGrant/award (A): 34,500 (derivative) @ $0EDGAR
2021-07-294Potter Stephen W — Chief Business OfficerGrant/award (A): 60,000 (derivative) @ $0EDGAR
2021-07-294Washer Susan B. — President and CEO, DirectorGrant/award (A): 275,000 (derivative) @ $0EDGAR
2021-06-214Potter Stephen W — Chief Business OfficerGrant/award (A): 35,000 @ $0EDGAR
2020-12-184Rosen James — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-12-184Magovcevic-Liebisch Ivana — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-12-184Aliski William — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-12-184Koenig Scott — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-12-184VANLENT ANNE — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-12-184HURWITZ EDWARD — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-08-184Shearman Mark S — Chief Scientific OfficerTax withholding (F): 5,723 @ $5.77EDGAR

Recent 8-K events — APPLIED GENETIC TECHNOLOGIES CORP

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-12-018-K1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-10-248-K1.01 — Entry into a Material Definitive Agreement
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-08-268-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-08-128-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-07-148-K1.01 — Entry into a Material Definitive Agreement
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2022-06-108-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2022-05-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-05-098-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AGTC returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs